ProAxsis has developed a range of unique molecules, known as ProteaseTags ®, which have the capacity to rapidly and selectively bind active proteases, including those which are biomarkers of diagnostic and prognostic value.
ProteaseTags ® rapidly provide a visual readout of active proteases in complex biological samples with a high level of specificity and selectivity. In diseases characterised by abnormal protease action including but not limited to COPD, Bronchiectasis and Cystic Fibrosis. ProteaseTag ® test systems have the potential to be incorporated into Point of Care tests, Companion Diagnostics, and activity-based immunoassays.
Lorem ipsum dolor sit amet consectetur adipiscing.
Lorem ipsum dolor sit amet consectetur adipiscing.
Lorem ipsum dolor sit amet consectetur adipiscing.
Duis condimentum nunc metus, maximus porta velit temporin.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massaum sociis natoque penatibus.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massaum sociis natoque penatibus.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massaum sociis natoque penatibus.
Curabitur vehicula tincidunt sapien velcac dolore laudantium.
Copyright © 2023 ProAxsis. All Rights Reserved
Automated page speed optimizations for fast site performance